Healthcare Services Group, Inc. (HCSG)

NASDAQ

$19.36

-$0.01 (0.05%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$19.01$19.59

Open $19.38

52 Week Range

$9.13$20.00

Previous Close $19.37

Market Cap1.42B

Volume622.86K

Avg Volume690.35K

P/E (TTM)35.58

EPS (TTM)$0.54

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$22.00

Based on 2 analysts (last year)

High Target

$22.00

Low Target

$22.00

Potential upside of 13.64%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$22.00

1 analysts

Last Year

$17.50

2 analysts

All Time

$17.40

5 analysts

Analyst Consensus

Current Consensus

Buy

Based on 14 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

A-

(Score: 4)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity3/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits4/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share2/5

P/BPrice to Book - Ratio comparing market price to company's book value per share3/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Oct 28, 2025	Unknown	UBS	$22.00	$18.85	+16.71%
Apr 24, 2025	Andrew Wittmann	Robert W. Baird	$13.00	$12.77	+1.80%
Jul 25, 2024	Andrew Wittmann	Robert W. Baird	$14.00	$11.07	+26.41%
Apr 21, 2022	Unknown	Credit Suisse	$18.00	$19.91

Recent Analyst Actions


Oct 28, 2025	Maintained	UBS	Buy	Buy
Oct 23, 2025	Maintained	Benchmark	Buy	Buy
Jul 29, 2025	Upgrade	Macquarie	Neutral	Outperform
Jul 24, 2025	Maintained	Benchmark	Buy	Buy
Jul 24, 2025	Maintained	Baird	Neutral	Neutral

Showing 1 to 5 of 162 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$22.00

Based on 2 analysts (last year)

High Target

$22.00

Low Target

$22.00

Potential upside of 13.64%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$22.00

1 analysts

Last Year

$17.50

2 analysts

All Time

$17.40

5 analysts

Analyst Consensus

Current Consensus

Buy

Based on 14 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

A-

(Score: 4)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity3/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits4/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share2/5

P/BPrice to Book - Ratio comparing market price to company's book value per share3/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Oct 28, 2025	Unknown	UBS	$22.00	$18.85	+16.71%
Apr 24, 2025	Andrew Wittmann	Robert W. Baird	$13.00	$12.77	+1.80%
Jul 25, 2024	Andrew Wittmann	Robert W. Baird	$14.00	$11.07	+26.41%
Apr 21, 2022	Unknown	Credit Suisse	$18.00	$19.91

Recent Analyst Actions


Oct 28, 2025	Maintained	UBS	Buy	Buy
Oct 23, 2025	Maintained	Benchmark	Buy	Buy
Jul 29, 2025	Upgrade	Macquarie	Neutral	Outperform
Jul 24, 2025	Maintained	Benchmark	Buy	Buy
Jul 24, 2025	Maintained	Baird	Neutral	Neutral

Showing 1 to 5 of 162 entries